Pyrogenic and Inflammatory Actions of Cytokines and Their Modulation by Neuropeptides: Techniques and Interpretations

[1]  Hubert Vaudry,et al.  The Melanotropic Peptides , 1993 .

[2]  D. Ottoson,et al.  Neuro-Immunology of Fever , 1992 .

[3]  J. M. Lipton,et al.  α-MSH peptides inhibit acute inflammation induced in mice by rIL-1β, rIL-6, rTNF-α and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8 , 1992 .

[4]  J. Weiss,et al.  Human immunodeficiency virus glycoprotein (gp120) infused into rat brain induces interleukin 1 to elevate pituitary-adrenal activity and decrease peripheral cellular immune responses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Thompson,et al.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. , 1991, Immunology today.

[6]  J. M. Lipton,et al.  Inhibition of acute inflammation in the periphery by central action of salicylates. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. M. Lipton,et al.  Anti-inflammatory activity of α-MSH(11–13) analogs: Influences of alteration in stereochemistry , 1991, Peptides.

[8]  J. M. Lipton,et al.  Central administration of the peptide α-MSH inhibits inflammation in the skin , 1991, Peptides.

[9]  M. Perretti,et al.  α-melanocyte-stimulating hormone reduces interleukin-lβ effects on rat stomach preparations possibly through interference with a type I receptor , 1991 .

[10]  J. Schröder,et al.  Inflammatory properties of neutrophil-activating protein-1/interleukin 8 (NAP-1/IL-8) in human skin: a light- and electronmicroscopic study. , 1991, The Journal of investigative dermatology.

[11]  J. M. Lipton,et al.  Dexamethasone facilitates release of the neuropeptide α-MSH , 1991, Brain Research Bulletin.

[12]  J. M. Lipton,et al.  Neuropeptide α-MSH antagonizes IL-6- and TNF-induced fever , 1991, Peptides.

[13]  T. Skak-Nielsen,et al.  Recombinant human interleukin-8 is a potent activator of canine neutrophil aggregation, migration, and leukotriene B4 biosynthesis. , 1991, The Journal of investigative dermatology.

[14]  J. Weiss,et al.  Effects of interleukin-1 infused into brain are antagonized by α-MSH in a dose-dependent manner , 1991 .

[15]  K. Matsushima,et al.  Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. , 1990, The Journal of biological chemistry.

[16]  E. D. De Souza,et al.  Interleukin-1 receptors in mouse brain: characterization and neuronal localization. , 1990, Endocrinology.

[17]  Giovanni Camussi,et al.  The role of platelet-activating factor in inflammation. , 1990, Clinical immunology and immunopathology.

[18]  A. Basbaum,et al.  Denervation-induced inflammation in the rat , 1990, Neuroscience Letters.

[19]  Robert A. Lewis,et al.  Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. , 1990, The New England journal of medicine.

[20]  J. M. Lipton,et al.  Alpha-MSH peptides inhibit acute inflammation and contact sensitivity , 1990, Peptides.

[21]  S. Akira,et al.  Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF) , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  A. Mantovani,et al.  Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6 , 1990, The Journal of experimental medicine.

[23]  J. M. Lipton,et al.  Modulation of host defense by the neuropeptide alpha-MSH. , 1990, The Yale journal of biology and medicine.

[24]  Stitt Jt.  Passage of immunomodulators across the blood-brain barrier. , 1990, The Yale journal of biology and medicine.

[25]  W. Banks,et al.  Bidirectional transport of interleukin-1 alpha across the blood-brain barrier , 1989, Brain Research Bulletin.

[26]  J. M. Lipton,et al.  Antiinflammatory activity of a COOH‐terminal fragment of the neuropeptide α‐MSH , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  J. Weiss,et al.  Intracerebroventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Basbaum,et al.  Neural control of vascular permeability: interactions between primary afferents, mast cells, and sympathetic efferents. , 1989, Journal of neurophysiology.

[29]  G. Camussi,et al.  Tumor necrosis factor stimulates human neutrophils to release leukotriene B4 and platelet-activating factor , 1989 .

[30]  E. Goetzl,et al.  Neuroimmune Networks: Physiology and Diseases , 1989 .

[31]  D. V. Van Epps,et al.  Modulation of IL-1, tumor necrosis factor, and C5a-mediated murine neutrophil migration by alpha-melanocyte-stimulating hormone. , 1989, Journal of immunology.

[32]  J. M. Lipton,et al.  Antipyretic properties of centrally administered α-MSH fragments in the rabbit , 1988, Peptides.

[33]  R. Zinkernagel,et al.  Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients , 1988, The Journal of experimental medicine.

[34]  R. Daynes,et al.  Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. , 1988, Journal of immunology.

[35]  M. Cybulsky,et al.  Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor. Synergistic action of the cytokines in the induction of inflammation and microvascular injury. , 1987, The American journal of pathology.

[36]  J. B. Tatro,et al.  Specific receptors for alpha-melanocyte-stimulating hormone are widely distributed in tissues of rodents. , 1987, Endocrinology.

[37]  A. Basbaum,et al.  Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides. , 1987, Rheumatic diseases clinics of North America.

[38]  R. Daynes,et al.  Alpha-melanocyte-stimulating hormone exhibits target cell selectivity in its capacity to affect interleukin 1-inducible responses in vivo and in vitro. , 1987, Journal of immunology.

[39]  J. M. Lipton,et al.  Is the endogenous antipyretic neuropeptide α-MSH responsible for reduced fever in aged rabbits? , 1987, Peptides.

[40]  F. Breviario,et al.  Modulation of endothelial cell functions by different molecular species of interleukin 1. , 1987, Blood.

[41]  J. M. Lipton,et al.  Antipyretic activity of a potent α-MSH analog , 1985, Peptides.

[42]  J. Dayer,et al.  Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction? , 1984, Journal of immunology.

[43]  J. M. Lipton,et al.  Effect of α-MSH 11–13 (lysine-proline-valine) on fever in the rabbit , 1984, Peptides.

[44]  J. M. Lipton,et al.  Antipyretic potency of centrally administered alpha-melanocyte stimulating hormone. , 1983, Science.

[45]  J. M. Lipton,et al.  α-MSH injected into the septal region reduces fever in rabbits , 1983, Peptides.

[46]  M. Bergsneider,et al.  Comparative biological activities of highly potent active-site analogues of alpha-melanotropin. , 1982, Journal of medicinal chemistry.

[47]  J. M. Lipton,et al.  The effect of fever on central α-MSH concentrations in the rabbit , 1981, Peptides.

[48]  J. M. Lipton,et al.  Hypothermic and antipyretic effects of centrally administered ACTH (1–24) and α-melanotropin , 1981, Peptides.

[49]  V. Hruby,et al.  4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. M. Lipton,et al.  Central administration of peptides alters thermoregulation in the rabbit , 1980, Peptides.

[51]  W. Clark.  The antipyretic effects of acetaminophen and sodium salicylate on endotoxin-induced fevers in cats. , 1970, The Journal of pharmacology and experimental therapeutics.

[52]  I. L. Bennett,et al.  STUDIES ON THE PATHOGENESIS OF FEVER , 1953, The Journal of experimental medicine.

[53]  J. Powers.  The National Formulary , 1945, Public health reports.

[54]  A. Ninian Bruce,et al.  VASO‐DILATOR AXON‐REFLEXES , 1913 .

[55]  J. M. Lipton,et al.  Proopiomelanocortin-derived peptides and cytokines: relations in patients with acquired immunodeficiency syndrome. , 1993, Clinical immunology and immunopathology.

[56]  A. Falus,et al.  Histamine: an early messenger in inflammatory and immune reactions. , 1992, Immunology today.

[57]  A. Falus,et al.  Complement research: biosynthesis, genetics, immunoregulatory role and clinical studies. , 1992, Immunology today.

[58]  P. Mackowiak.  Fever : basic mechanisms and management , 1991 .

[59]  J. Warren,et al.  Interleukins and tumor necrosis factor in inflammation. , 1990, Critical reviews in clinical laboratory sciences.

[60]  C. Dinarello.  Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.

[61]  B. Beutler,et al.  Tumor necrosis, cachexia, shock, and inflammation: a common mediator. , 1988, Annual review of biochemistry.

[62]  E. Atkins.  THE YALE JOURNAL OF BIOLOGY AND MEDICINE 55 (1982), 283-289 Fever: Its History, Cause, and Function , 1982 .

[63]  W. Greenough,et al.  A stereotaxic atlas of the albino mouse forebrain. , 1980 .